<SEC-DOCUMENT>0001193125-24-135991.txt : 20240510
<SEC-HEADER>0001193125-24-135991.hdr.sgml : 20240510
<ACCEPTANCE-DATETIME>20240510131049
ACCESSION NUMBER:		0001193125-24-135991
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20240510
FILED AS OF DATE:		20240510
DATE AS OF CHANGE:		20240510

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Theratechnologies Inc.
		CENTRAL INDEX KEY:			0001512717
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A8
		FISCAL YEAR END:			1130

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35203
		FILM NUMBER:		24933936

	BUSINESS ADDRESS:	
		STREET 1:		2015 PEEL STREET
		STREET 2:		5TH FLOOR
		CITY:			MONTREAL
		STATE:			A8
		ZIP:			H3A 1T8
		BUSINESS PHONE:		514-336-7800

	MAIL ADDRESS:	
		STREET 1:		2015 PEEL STREET
		STREET 2:		5TH FLOOR
		CITY:			MONTREAL
		STATE:			A8
		ZIP:			H3A 1T8
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>d800004d6k.htm
<DESCRIPTION>6-K
<TEXT>
<HTML><HEAD>
<TITLE>6-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:4.5pt;margin-top:0pt;margin-bottom:2pt;border-bottom:4.50pt solid #000000">&nbsp;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES
AND EXCHANGE COMMISSION </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C.&nbsp;20549 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>FORM 6-K </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Report of
Foreign Private Issuer </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant to Rule 13a-16 or 15d-16 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>under the Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">May 10, 2024 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Commission File
Number 001-35203 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:22pt; font-family:Times New Roman" ALIGN="center"><B>THERATECHNOLOGIES INC. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Translation of registrant&#146;s name into English) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2015 Peel Street, Suite 1100 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Montr&eacute;al, Qu&eacute;bec, Canada </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">H3A 1T8 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Address of principal
executive offices) </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form
40-F: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Form 20-F&#8194;&#9746;&#8195;&#8195;&#8195;&#8195;Form 40-F&#8194;&#9744;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Yes&#8194;&#9744;&#8195;&#8195;&#8195;&#8195;No&#8194;&#9746; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report
to security holders. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule
101(b)(7): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Yes&#8194;&#9744;&#8195;&#8195;&#8195;&#8195;No&#8194;&#9746; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that
the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant&#146;s &#147;home country&#148;), or under the rules of the
home country exchange on which the registrant&#146;s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant&#146;s security holders, and, if
discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Indicate by check
mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Yes&#8194;&#9744;&#8195;&#8195;&#8195;&#8195;No&#8194;&#9746; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If &#147;Yes&#148; is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):
82-<U>&#8195;&#8195;&#8195;&#8195;&#8195;</U>. </P> <P STYLE="line-height:10.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:4.50pt solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>THERATECHNOLOGIES INC.</U> </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:7.5pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="93%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7.5pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:7.5pt; font-family:Times New Roman; " ALIGN="center"><B>Exhibit</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7.5pt; font-family:Times New Roman" ALIGN="justify"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><A HREF="d800004dex991.htm">Report on Voting Results Following the Annual Meeting of Shareholders Held on May 9, 2024
</A></P></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:9pt; margin-bottom:0pt; text-indent:5%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized. </P> <P STYLE="font-size:13pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">THERATECHNOLOGIES INC.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">By:&#8194;/s/&#8201;&#8201;Jocelyn Lafond</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Name:&#8194;Jocelyn Lafond</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Title:&#8199;&#8199;General Counsel
and Corporate Secretary</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Date: May 10, 2024 </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d800004dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g800004snap111.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B>REPORT ON VOTING RESULTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B>ANNUAL MEETING OF SHAREHOLDERS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B>HELD ON MAY&nbsp;9, 2024 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="justify">The Annual Meeting of Shareholders (the &#147;<B>Meeting</B>&#148;) of Theratechnologies was held online via a live audio webcast on Thursday,
May&nbsp;9, 2024, at 10:00 a.m. (Eastern Time). At least two&nbsp;shareholders and/or proxy holders were present at the Meeting, in person or by proxy, holding 30,802,072 common shares of Theratechnologies, representing approximately 66.99% of the
total votes attached to all issued and outstanding shares of Theratechnologies as of the record date on April&nbsp;4, 2024. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman"><B>Election of Directors
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="justify">All eight directors proposed for election at the Meeting were elected by a vote conducted by ballot. All candidates were elected by a
majority of the votes cast by shareholders present or represented by proxy at the Meeting. The directors will remain in office until the next annual meeting of shareholders or until their successors are elected or appointed. The votes cast for the
election of directors were as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="98%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt" ALIGN="center">


<TR>

<TD WIDTH="43%"></TD>

<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="14%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="14%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="14%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center"><B>Votes For</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center"><B>Votes Withheld</B></TD>
<TD VALIGN="bottom" ROWSPAN="10">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="10" ALIGN="center"><B>&emsp;&#8196;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>#</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>%</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>#</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>%</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Joseph Arena</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">22,405,047</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">93.09</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">1,663,754</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">6.91</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Frank Holler</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">21,008,601</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">87.29</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">3,060,200</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">12.71</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Paul L&eacute;vesque</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">20,966,427</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">87.11</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">3,102,374</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">12.89</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Andrew Molson</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">21,067,050</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">87.53</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">3,001,751</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">12.47</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Dawn Svoronos</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">20,964,213</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">87.10</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">3,104,588</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">12.90</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Elina Tea</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">21,734,254</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">90.30</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">2,334,547</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">9.70</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Dale Weil</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">21,009,681</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">87.29</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">3,059,120</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">12.71</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Jordan Zwick</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">23,107,383</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">96.01</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">961,418</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">3.99</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman"><B>Appointment of Auditors </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="justify">The resolution to appoint KPMG LLP, chartered professional accountants, as Theratechnologies&#146; auditors to hold office until the next
annual meeting of shareholders or until their successors are appointed, and to authorize the directors to fix their remuneration, was passed by a majority of the votes cast by ballot by the shareholders present or represented by proxy at the
Meeting. The votes cast for the appointment of the auditors were as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="98%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt" ALIGN="center">


<TR>

<TD WIDTH="42%"></TD>

<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="14%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="14%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="14%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center"><B>Votes For</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center"><B>Votes Withheld</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3" ALIGN="center"><B>&ensp;&#8196;&#8198;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>#</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>%</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>#</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>%</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:11pt; font-family:Times New Roman">Auditors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">30,037,739</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">97.53</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">760,808</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">2.47</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g800004snap111.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g800004snap111.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M6R=_=5VKV6QY5;BK >V4:&&E)IZ6A3WYFEI&KZ&8?^"F?@YN/^%5^,%3H?\
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MSK_;$.D%_P"V)'N%M96FFVL1;[< ,<7[.-_3T_R.RGE%-6YK:>G1?X"CXC^
MOB+5I?&%AI7Q/UO1_!OCF\N;WQ#X5GT/3-<FB?4%VZY;Z)K^JXN;""\_Y9"-
M L'5>G#]G'7I??857**;O9+7?1/L]^0^B=(TN'1=*TW1]/W166E65MIUJLN9
M)/(LHEMXBS$_W(UIGM&O0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
? %*!BT\X.,*1MPJJ1@]V !/3N: +M !0 4 % '__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
